Maximus, Inc. (NYSE:MMS) insider Mark Andrekovich sold 5,000 shares of Maximus stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $68.80, for a total transaction of $344,000.00. Following the completion of the transaction, the insider now directly owns 22,996 shares of the company’s stock, valued at $1,582,124.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Mark Andrekovich also recently made the following trade(s):

  • On Wednesday, November 22nd, Mark Andrekovich sold 5,594 shares of Maximus stock. The stock was sold at an average price of $67.23, for a total transaction of $376,084.62.

Shares of Maximus, Inc. (NYSE:MMS) opened at $70.82 on Friday. Maximus, Inc. has a 12 month low of $51.74 and a 12 month high of $70.83. The company has a market cap of $4,568.68, a P/E ratio of 22.55, a PEG ratio of 2.63 and a beta of 1.35.

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 30th. Investors of record on Wednesday, November 15th were given a dividend of $0.045 per share. The ex-dividend date was Tuesday, November 14th. This represents a $0.18 annualized dividend and a yield of 0.25%. Maximus’s dividend payout ratio (DPR) is 5.66%.

Several brokerages have issued reports on MMS. Zacks Investment Research raised shares of Maximus from a “hold” rating to a “buy” rating and set a $73.00 target price for the company in a report on Wednesday, October 4th. Robert W. Baird started coverage on shares of Maximus in a report on Sunday, September 3rd. They issued a “neutral” rating for the company. Finally, Canaccord Genuity reduced their price target on shares of Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research note on Friday, November 10th. Two equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $64.33.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Janus Henderson Group PLC boosted its position in shares of Maximus by 718.8% in the second quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock worth $138,515,000 after purchasing an additional 1,941,521 shares during the period. Koch Industries Inc. bought a new position in shares of Maximus in the second quarter worth approximately $629,000. FMR LLC boosted its position in shares of Maximus by 10.4% in the second quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock worth $291,767,000 after purchasing an additional 438,025 shares during the period. Victory Capital Management Inc. boosted its position in shares of Maximus by 13.3% in the third quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock worth $226,667,000 after purchasing an additional 413,325 shares during the period. Finally, Trilogy Global Advisors LP bought a new position in shares of Maximus in the second quarter worth approximately $17,325,000. Institutional investors own 94.82% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/maximus-inc-mms-insider-sells-344000-00-in-stock/1753617.html.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.